Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 26

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 26
---
 of Depositary Shares
are issued and sold at a price of $1.00 per share (and excluding any Commitment Shares offered hereby). The Depositary Shares that may
be issued under the Purchase Agreement may be sold, subject to the restrictions and satisfaction of the conditions in the Purchase Agreement,
by us to the Selling Shareholder at our discretion from time to time from the Commencement Date (as defined below) until the earliest
to occur of (i) the first day of the month next following the 36-month anniversary of the Commencement Date, (ii) the date on which the
Selling Shareholder shall have purchased the Commitment Amount, (iii) the ninetieth day after the date on which, pursuant to or within
the meaning of any bankruptcy law, we commence a voluntary case or any person commences a proceeding against us, in each case that is
not discharged or dismissed prior to such ninetieth day, and (iv) the date on which, pursuant to or within the meaning of any bankruptcy
law, a custodian is appointed for us or for all or substantially all of our property, or we make a general assignment for the benefit
of our creditors, or each, a Termination Event.

We do not have a right to
commence any sales of Depositary Shares to the Selling Shareholder under the Purchase Agreement until the time when all of the conditions
to our right to commence sales of Depositary Shares to the Selling Shareholder set forth in the Purchase Agreement have been satisfied,
or the Commencement Date, including the effectiveness of the registration statement of which this prospectus forms a part. Over the 36-month
period from and after the Commencement Date, we will generally have the right to control the timing and amount of any sales of our Depositary
Shares to the Selling Shareholder under the Purchase Agreement. Sales of our Depositary Shares, if any, to the Selling Shareholder under
the Purchase Agreement will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to
the Selling Shareholder all, some or none of the Depositary Shares that may be available for us to sell to the Selling Shareholder pursuant
to the Purchase Agreement. Accordingly, we cannot guarantee that we will be able to sell all of the Commitment Amount or how much in proceeds
we may obtain under the Purchase Agreement. If we cannot sell securities under the Committed Equity Financing, we may be required to utilize
more